Your browser doesn't support javascript.
loading
Clinical experience of idarucizumab use in cases of cardiac tamponade under uninterrupted anticoagulation of dabigatran during catheter ablation of atrial fibrillation.
Okishige, Kaoru; Yamauchi, Yasuteru; Hanaki, Yuichi; Inoue, Koichi; Tanaka, Nobuaki; Yamaji, Hirosuke; Murakami, Takashi; Manita, Mamoru; Tabata, Kazuhiro; Ooie, Tatsuhiko; Tatsukawa, Youichi; Sakai, Hirotsuka; Yamaki, Masaru; Murakami, Masato; Takada, Takuma; Osaka, Yuki; Ono, Yuichi; Handa, Keita; Sugiyama, Koji; Yoshizawa, Tomoharu; Fukaya, Hidehira; Tashiro, Hideki; Takase, Susumu; Harada, Masahide; Watanabe, Eiichi; Yamane, Teiichi; Yamashita, Seigo; Aonuma, Kazutaka.
Affiliation
  • Okishige K; Japan Red Cross Yokohama City Bay Hospital, Kanagawa, Japan. okishige@yo.rim.or.jp.
  • Yamauchi Y; Japan Red Cross Yokohama City Bay Hospital, Kanagawa, Japan.
  • Hanaki Y; University of Tsukuba School of Medicine, Ibaraki, Japan.
  • Inoue K; Sakurabashi Watanabe Hospital, Osaka, Japan.
  • Tanaka N; Sakurabashi Watanabe Hospital, Osaka, Japan.
  • Yamaji H; Okayama Heart Clinic, Okayama, Japan.
  • Murakami T; Okayama Heart Clinic, Okayama, Japan.
  • Manita M; Naha City Hospital, Okinawa, Japan.
  • Tabata K; Naha City Hospital, Okinawa, Japan.
  • Ooie T; Oita Oka Hospital, Oita, Japan.
  • Tatsukawa Y; Oita Oka Hospital, Oita, Japan.
  • Sakai H; Nayoro City General Hospital, Hokkaido, Japan.
  • Yamaki M; Nayoro City General Hospital, Hokkaido, Japan.
  • Murakami M; Shonan Kamakura General Hospital, Kanagawa, Japan.
  • Takada T; Shonan Kamakura General Hospital, Kanagawa, Japan.
  • Osaka Y; Ome Municipal General Hospital, Tokyo, Japan.
  • Ono Y; Ome Municipal General Hospital, Tokyo, Japan.
  • Handa K; Kashiwa Municipal Hospital, Chiba, Japan.
  • Sugiyama K; Kashiwa Municipal Hospital, Chiba, Japan.
  • Yoshizawa T; Kitasato University School of Medicine, Kanagawa, Japan.
  • Fukaya H; Kitasato University School of Medicine, Kanagawa, Japan.
  • Tashiro H; St.Mary's Hospital, Fukuoka, Japan.
  • Takase S; St.Mary's Hospital, Fukuoka, Japan.
  • Harada M; Fujita Health University School of Medicine, Aichi, Japan.
  • Watanabe E; Fujita Health University School of Medicine, Aichi, Japan.
  • Yamane T; Jikei University School of Medicine, Tokyo, Japan.
  • Yamashita S; Jikei University School of Medicine, Tokyo, Japan.
  • Aonuma K; University of Tsukuba School of Medicine, Ibaraki, Japan.
J Thromb Thrombolysis ; 47(4): 487-494, 2019 May.
Article in En | MEDLINE | ID: mdl-30955142
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Cardiac Tamponade / Catheter Ablation / Antibodies, Monoclonal, Humanized / Dabigatran Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Thromb Thrombolysis Journal subject: ANGIOLOGIA Year: 2019 Document type: Article Affiliation country: Japón Country of publication: Países Bajos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Cardiac Tamponade / Catheter Ablation / Antibodies, Monoclonal, Humanized / Dabigatran Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Thromb Thrombolysis Journal subject: ANGIOLOGIA Year: 2019 Document type: Article Affiliation country: Japón Country of publication: Países Bajos